Author(s): Manjunath Shetty, Smita Shenoy, Nitesh Kumar, Arul Amuthan, Ganesh Shenoy, Vasudha Devi, Akshatha, Mohandas Rao


DOI: 10.52711/0974-360X.2023.00979   

Address: Manjunath Shetty1, Smita Shenoy2*, Nitesh Kumar3, Arul Amuthan1, Ganesh Shenoy1, Vasudha Devi2, Akshatha4, Mohandas Rao5
1Division of Pharmacology, Department of Basic Medical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India – 576104.
2Department of Pharmacology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India – 576104.
3Department of Pharmacology and Toxicology, NIPER, Hajipur, Bihar, India – 844102.
4Department of Research and Development, Muniyal Institute of Ayurveda and Medical Sciences, Manipal, Karnataka, India – 576104.
5Division of Anatomy, Department of Basic Medical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India – 576104.
*Corresponding Author

Published In:   Volume - 16,      Issue - 12,     Year - 2023

The study explores the hepatoprotective effect of Kadukkai maathirai (KM) in high fat diet (HFD) induced nonalcoholic fatty liver disease (NAFLD) in rats. Total 54 Sprague Dawley rats were used in the study, 9 groups: Group I – IV kept as normal and test drug control and group V - NAFLD disease model- received HFD for 40 weeks. Group VI – IX received HFD for 40 weeks and then test drugs: Group VI – VIII received KM in three different doses for 45 days. Metformin (standard) was administered to Group IX for 45 days. On day 46, the blood and liver tissue were collected for analysis. KM at 36, 144mg/kg and metformin showed a significant decrease in ALP level, all three doses of KM and metformin showed a significant reduction in direct bilirubin levels. A significant improvement in HDL was observed in all doses of KM and metformin-treated groups. Oral glucose tolerance test (OGTT) findings in KM treated test groups showed significantly reduced plasma glucose levels. The KM treated groups and metformin-treated groups showed a reduction in body weight at 47th week, and significantly reduced relative liver weight when compared with the HFD group. Histopathological evaluation of KM treated groups showed normal architecture of central vein and hepatic cords. Portal triads were also generally normal in their location and pattern. No indication of fatty liver. This study confirms the ability of phytoconstituents present in KM in reversing the metabolic dysfunction and liver pathology seen in NAFLD. Further studies are required to evaluate KM as a therapeutic agent.

Cite this article:
Manjunath Shetty, Smita Shenoy, Nitesh Kumar, Arul Amuthan, Ganesh Shenoy, Vasudha Devi, Akshatha, Mohandas Rao. Kadukkai maathirai (Siddha herbal formulation) reverses liver pathology associated with metabolic dysfunction in high fat diet-induced fatty liver disease – a preclinical study. Research Journal of Pharmacy and Technology.2023; 16(12):6032-8. doi: 10.52711/0974-360X.2023.00979

Manjunath Shetty, Smita Shenoy, Nitesh Kumar, Arul Amuthan, Ganesh Shenoy, Vasudha Devi, Akshatha, Mohandas Rao. Kadukkai maathirai (Siddha herbal formulation) reverses liver pathology associated with metabolic dysfunction in high fat diet-induced fatty liver disease – a preclinical study. Research Journal of Pharmacy and Technology.2023; 16(12):6032-8. doi: 10.52711/0974-360X.2023.00979   Available on:

1.    Wree A, Broderick L, Canbay A, Hoffman HM, Feldstein AE. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nature reviews Gastroenterology and Hepatology. 2013;10(11):627-636. doi:10.1038/nrgastro.2013.149
2.    Michelotti GA, Machado M V, Diehl AM. NAFLD, NASH and liver cancer. Nature reviews Gastroenterology and Hepatology. 2013;10(11):656-665. doi:10.1038/nrgastro.2013.183
3.    Zhu J-Z, Dai Y-N, Wang Y-M, Zhou Q-Y, Yu C-H, Li Y-M. Prevalence of Nonalcoholic Fatty Liver Disease and Economy. Digestive Diseases and Sciences. 2015; 60(11): 3194-3202. doi:10.1007/s10620-015-3728-3
4.    Fan J-G, Kim S-U, Wong VW-S. New trends on obesity and NAFLD in Asia. Journal of Hepatology. 2017; 67(4): 862-873. doi:10.1016/j.jhep.2017.06.003
5.    Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature reviews Gastroenterology and Hepatology. 2018; 15(1): 11-20. doi:10.1038/nrgastro.2017.109
6.    Chavan S, Dias R, Magdum C. Evaluation of Hepatoprotective activity of Ethanolic Extract of Garuga pinnata Roxburgh leaves against Carbon tetrachloride induced Hepatotoxicity in rats. Research Journal of Pharmacy and Technology. 2021: 2375-2380. doi:10.52711/0974-360X.2021.00419
7.    Seto W-K, Yuen M-F. Nonalcoholic fatty liver disease in Asia: emerging perspectives. Journal of Gastroenterology. 2017; 52(2): 164-174. doi:10.1007/s00535-016-1264-3
8.    Choudhari S, Jothipriya MA. Non-alcoholic fatty liver disease. Research Journal of Pharmacy and Technology. 2016; 9(10): 1782. doi:10.5958/0974-360X.2016.00360.7
9.    Hassoon Ali K, Al-Jawad FH, Mahmood Kadhim H. The Possible Hepatoprotecive Effects of Krill Oil and Silymarin against Carbon Tetrachloride (CCl4)-Induced Rats Model of Liver Fibrosis: In Vivo Study. Research Journal of Pharmacy and Technology. 2021: 5953-5958. doi:10.52711/0974-360X.2021.01034
10.    Polyzos SA, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Current Molecular Medicine. 2009; 9(3): 299-314. doi:10.2174/156652409787847191
11.    Duvnjak M, Lerotić I, Barsić N, Tomasić V, Virović Jukić L, Velagić V. Pathogenesis and management issues for non-alcoholic fatty liver disease. World Journal of Gastroenterology. 2007; 13(34): 4539-4550. doi:10.3748/wjg.v13.i34.4539
12.    Gossard AA, Lindor KD. Current therapies for nonalcoholic fatty liver disease. Drugs of today (Barcelona, Spain : 1998). 2011;47(12):915-922. doi:10.1358/dot.2011.47.12.1688530
13.    Keating SE, Hackett DA, George J, Johnson NA. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Journal of Hepatology. 2012;57(1):157-166. doi:10.1016/j.jhep.2012.02.023
14.    Firenzuoli F, Gori L. Herbal medicine today: clinical and research issues. Evidence-based complementary and alternative medicine : eCAM. 2007;4(Suppl 1):37-40. doi:10.1093/ecam/nem096
15.    Riyaniarti MM, Estri W, Widodo N, Widjajanto E, Jatmiko YD, Muhaimin R. Red Moringa oleifera leaf fermentation extract protecting hepatotoxicity in balb/c mice injected with Salmonella typhi through Nrf-2, HO-1, and SOD-2 signaling pathways. Research Journal of Pharmacy and Technology. 2020; 13(12): 5947-5952. doi:10.5958/0974-360X.2020.01038.0
16.    Velayudam, Ilavarasan AA. Physico-chemical evaluation of kadukkai maathirai and its tablet formulation, a siddha iron preparation used in anemia. Int J Pharmacol Clin Sci. 2012; 1: 3-8.
17.    Wagner H, Geyer B, Kiso Y, Hikino H, Rao G. Coumestans as the Main Active Principles of the Liver Drugs Eclipta alba and Wedelia calendulacea 1. Planta Medica. 1986; 52(5): 370-374. doi:10.1055/s-2007-969188
18.    Vijayakumar RS, Surya D, Nalini N. Antioxidant efficacy of black pepper ( Piper nigrum L.) and piperine in rats with high fat diet induced oxidative stress. Redox Report. 2004; 9(2): 105-110. doi:10.1179/135100004225004742
19.    Selvendiran K, Sakthisekaran D. Chemopreventive effect of piperine on modulating lipid peroxidation and membrane bound enzymes in benzo(a)pyrene induced lung carcinogenesis. Biomedicine and Pharmacotherapy. 2004; 58(4): 264-267. doi:10.1016/j.biopha.2003.08.027
20.    Lieber CS, Leo MA, Mak KM, et al. Model of nonalcoholic steatohepatitis. American Journal of Clinical Nutrition. 2004; 79(3): 502-509. doi:10.1093/ajcn/79.3.502
21.    Zou Y, Li J, Lu C, et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sciences. 2006; 79(11): 1100-1107. doi:10.1016/j.lfs.2006.03.021
22.    Premlata Rathore, S. Prakash Rao, Amit Roy, Trilochan Satapathy, Vijay Singh PJ. Hepatoprotective Activity of Isolated Herbal Compounds. Research Jornal of Pharmacy and Technology. 7(2): 229-234.
23.    Rahman I, Kode A, Biswas SK. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nature Protocols. 2007; 1(6): 3159-3165. doi:10.1038/nprot.2006.378
24.    Bonner-Weir S. Morphological Evidence for Pancreatic Polarity of -Cell Within Islets of Langerhans. Diabetes. 1988; 37(5): 616-621. doi:10.2337/diab.37.5.616
25.    Carmiel-Haggai M, Cederbaum AI, Nieto N. A high‐fat diet leads to the progression of non‐alcoholic fatty liver disease in obese rats. The FASEB Journal. 2005; 19(1): 136-138. doi:10.1096/fj.04-2291fje
26.    van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiology and Behavior. 2008;94(2):231-241. doi:10.1016/j.physbeh.2007.11.049
27.    Xu R, Wan Y, Tang Q, Wu J, Cai W. The effects of high fat on central appetite genes in Wistar rats: a microarray analysis. Clinica chimica acta; international journal of clinical chemistry. 2008;397(1-2):96-100. doi:10.1016/j.cca.2008.07.027
28.    Buettner R, Parhofer KG, Woenckhaus M, et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. Journal of Molecular Endocrinology. 2006; 36(3): 485-501. doi:10.1677/jme.1.01909
29.    Kandasamy C.S, E. Mohammed Basil, P.S. Shimna Thasnim, Kumar R. Siva, Gopal V VR. Hepatoprotective Activity of Polyherbal Formulation Containing Some Indigenous Medicinal Plants in Rats. Research Journal of Pharmacy and Technology. 2010; 3(3): 828-831.
30.    Safwat GM, Pisanò S, D’Amore E, et al. Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect? Nutrition. 2009; 25(11-12): 1157-1168. doi:10.1016/j.nut.2009.02.009
31.    Azwan K, Mona R, Firdous J, Keumala Sari D, Rosie David P, Muhamad N. Eight weeks consumption of high-fat diet promotes Mesenteric fat deposition when compared to other rat diets. Research Journal of Pharmacy and Technology. 2022: 571-574. doi:10.52711/0974-360X.2022.00093
32.    Liguori I, Russo G, Curcio F, et al. Oxidative stress, aging, and diseases. Clinical Interventions in Aging. 2018;Volume 13:757-772. doi:10.2147/CIA.S158513
33.    Alva SS, Joshi H, Gururaja MP, Shama KP, D’souza UP. Anti-Obesity Activity of Vateria indica linn. Stem Bark in Rats. Research Journal of Pharmacy and Technology. 2018; 11(12): 5238. doi:10.5958/0974-360X.2018.00955.1
34.    Wardani E, Harahap Y, Mun’im A, Bahtiar A. Evaluation of the combination of Kemuning Leaves Extracts and Simvastatin on Blood fatty acids and amino acids of Hyperlipidemic Model Rats. Research Journal of Pharmacy and Technology. 2021: 2076-2080. doi:10.52711/0974-360X.2021.00368
35.    Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. Journal of Lipid Research. 1995; 36(2): 211-228. doi:10.1016/S0022-2275(20)39898-9
36.    Kingwell BA, Chapman MJ, Kontush A, Miller NE. HDL-targeted therapies: progress, failures and future. Nature Reviews Drug Discovery. 2014; 13(6): 445-464. doi:10.1038/nrd4279
37.    Svegliati-Baroni G, Candelaresi C, Saccomanno S, et al. A Model of Insulin Resistance and Nonalcoholic Steatohepatitis in Rats. The American Journal of Pathology. 2006; 169(3): 846-860. doi:10.2353/ajpath.2006.050953
38.    Belfiore F, Iannello S. Insulin Resistance in Obesity: Metabolic Mechanisms and Measurement Methods. Molecular Genetics and Metabolism. 1998; 65(2): 121-128. doi:10.1006/mgme.1998.2727
39.    Gao H, Huang Y-N, Gao B, Kawabata J. Chebulagic Acid Is a Potent α-Glucosidase Inhibitor. Bioscience, Biotechnology, and Biochemistry. 2008; 72(2): 601-603. doi:10.1271/bbb.70591
40.    Subramanian G, Shanmugamprema D, Subramani R, et al. Anti‐Obesity Effect of T. Chebula Fruit Extract on High Fat Diet Induced Obese Mice: A Possible Alternative Therapy. Molecular Nutrition and Food Research. 2021; 65(10): 2001224. doi:10.1002/mnfr.202001224
41.    Wang L, Palme V, Rotter S, et al. Piperine inhibits ABCA1 degradation and promotes cholesterol efflux from THP-1-derived macrophages. Molecular Nutrition and Food Research. 2017; 61(4): 1500960. doi:10.1002/mnfr.201500960
42.    Parim B, Harishankar N, Balaji M, Pothana S, Sajjalaguddam RR. Effects of Piper nigrum extracts: Restorative perspectives of high-fat diet-induced changes on lipid profile, body composition, and hormones in Sprague–Dawley rats. Pharmaceutical Biology. 2015; 53(9): 1318-1328. doi:10.3109/13880209.2014.980585
43.    Koteish A, Mae Diehl A. Animal models of steatohepatitis. Best Practice and Research Clinical Gastroenterology. 2002; 16(5): 679-690. doi:10.1053/bega.2002.0332
44.    Gupta A, Kumar A, Kumar D, et al. Ecliptal, a promising natural lead isolated from Eclipta alba modulates adipocyte function and ameliorates metabolic syndrome. Toxicology and Applied Pharmacology. 2018;338:134-147. doi:10.1016/j.taap.2017.11.016
45.    Fukuchi Y, Hiramitsu M, Okada M, et al. Lemon Polyphenols Suppress Diet-induced Obesity by Up-Regulation of mRNA Levels of the Enzymes Involved in beta-Oxidation in Mouse White Adipose Tissue. Journal of clinical biochemistry and nutrition. 2008;43(3):201-209. doi:10.3164/jcbn.2008066
46.    Li J, Wang T, Liu P, et al. Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. Food and Function. 2021; 12(9): 3898-3918. doi:10.1039/D0FO02736G
47.    Choi S, Choi Y, Choi Y, Kim S, Jang J, Park T. Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice. Food Chemistry. 2013; 141(4): 3627-3635. doi:10.1016/j.foodchem.2013.06.028
48.    Liu C, Yuan Y, Zhou J, Hu R, Ji L, Jiang G. Piperine ameliorates insulin resistance via inhibiting metabolic inflammation in monosodium glutamate-treated obese mice. BMC Endocrine Disorders. 2020; 20(1): 152. doi:10.1186/s12902-020-00617-1
49.    BrahmaNaidu P, Nemani H, Meriga B, Mehar SK, Potana S, Ramgopalrao S. Mitigating efficacy of piperine in the physiological derangements of high fat diet induced obesity in Sprague Dawley rats. Chemico-Biological Interactions. 2014; 221: 42-51. doi:10.1016/j.cbi.2014.07.008
50.    Kashiwagi H, Asano E, Noguchi C, et al. Beneficial effect of D-allose for isolated islet culture prior to islet transplantation. Journal of Hepato-Biliary-Pancreatic Sciences. 2016; 23(1): 37-42. doi:10.1002/jhbp.298
51.    Kumar SP. Evaluation of Antioxidant activity of Ardisia solanacea in albino rats. Research Journal of Pharmacy and Technology. 2013; 6(5): 585-588.
52.    Kalko KO, Mishchenko OY, Derymedvid L V., et al. A Screening Study of Hepatoprotective Activity of Liquid Extract from Common Tansy Tanacetum vulgare L. Herb in the setting of Subchronic Hepatitis in Rats. Research Journal of Pharmacy and Technology. 2018; 11(10): 4393. doi:10.5958/0974-360X.2018.00803.X

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available